已收盘 12-24 16:00:00 美东时间
-1.060
-0.57%
今日重点评级关注:Ascendiant Capital:维持Society Pass"买入"评级,目标价从22美元升至22.5美元;HC Wainwright & Co.:维持Climb Bio"买入"评级,目标价从9美元升至11美元
12-19 10:15
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
12-18 10:54
Shares of energy stocks are trading lower. Russia-Ukraine ceasefire hopes have ...
12-17 02:07
Targa Resources (NYSE:TRGP) has outperformed the market over the past 15 years ...
12-09 05:45
今日重点评级关注:Guggenheim:维持Cybin Inc. Common Shares"买入"评级,目标价从39美元升至48美元;HC Wainwright & Co.:维持Capricor Therapeutics"买入"评级,目标价从24美元升至60美元
12-04 09:38
Targa Resources Corp. is acquiring Stakeholder Midstream, LLC for $1.25 billion in cash, enhancing its sour gas treating capabilities and expanding its gathering and processing footprint in the Permian Basin. The acquisition includes ~170,000 acres of long-term acreage dedications and fee-based contracts, stable volume profiles, and significant economic drilling opportunities. Targa expects minimal impact on leverage and ~$200 million in annual u...
12-01 12:00
今日重点评级关注:Oppenheimer:维持Olema Pharmaceuticals"跑赢大市"评级,目标价从22美元升至45美元;Bernstein:维持Atlassian"跑赢大市"评级,目标价从290美元升至304美元
11-19 11:01
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
11-14 10:43
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从12美元升至15美元;Canaccord Genuity:维持Viking Therapeutics"买入"评级,目标价从106美元升至107美元
11-13 09:58
Morgan Stanley analyst Robert Kad maintains Targa Resources (NYSE:TRGP) with a Overweight and raises the price target from $240 to $261.
11-13 01:24